Abstracts tagged "Cerebrovascular disease"

Abstract Number: 726 • 2014 ACR/ARHP Annual Meeting
Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-Analysis
Patompong Ungprasert¹, Praveen Ratanasrimetha², Charat Thongprayoon³, Wisit Cheungpasitporn³ and Promporn Suksaranjit⁴, ¹Department of Internal medicine, Bassett medical center, Cooperstown, NY, ²Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ³Department of Medicine, Mayo clinic, Rochester, MN, ⁴Department of Cardiology, University of Utah School of Medicine, Salt Lake City, UT
Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-analysisBackground/Purpose: Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus…
Abstract Number: 2856 • 2014 ACR/ARHP Annual Meeting
Update on Long-Term Outcomes after Reversible Cerebral Vasoconstriction Syndrome (RCVS)
Seby John¹, Aneesh Singhal², Leonard H. Calabrese³, Ken Uchino⁴, Tariq Hammad³, Stewart Tepper³, Mark Stillman³ and Rula A Hajj-Ali⁵, ¹9500 Euclid Avenue S10-C, Cleveland Clinic Foundation, Cleveland, OH, ²Neurology, Massachusetts General Hospital, Boston, MA, ³Cleveland Clinic Foundation, Cleveland, OH, ⁴Neurology, Cleveland Clinic Foundation, Cleveland, OH, ⁵Rheumatology, Cleveland Clinic Foundation, Cleveland, OH
Background/Purpose RCVS is characterized by acute onset of severe headaches, with or without neurologic deficit with evidence of reversible cerebral vasoconstriction. We have previously reported…
Abstract Number: 2765 • 2014 ACR/ARHP Annual Meeting
Putative Blood Biomarkers of Reversible Cerebral Vasoconstriction Syndrome
Seby John¹, Belinda Willard², Leonard H. Calabrese², Ken Uchino³, Tariq Hammad², Stewart Tepper², Mark Stillman² and Rula A Hajj-Ali⁴, ¹9500 Euclid Avenue S10-C, Cleveland Clinic Foundation, Cleveland, OH, ²Cleveland Clinic Foundation, Cleveland, OH, ³Neurology, Cleveland Clinic Foundation, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic Foundation, Cleveland, OH
Putative blood biomarkers of Reversible Cerebral Vasoconstriction Syndrome Background/Purpose The pathophysiology and molecular mechanisms of Reversible Cerebral Vasoconstriction Syndrome (RCVS) are unknown. Objective of the…
Abstract Number: 1852 • 2014 ACR/ARHP Annual Meeting
Increased Cardiovascular Risk in Patients Recently Diagnosed with Psoriatic Arthritis: A Population-Based, Cohort Study
Katelynn Wilton¹, Floranne C. Ernste², Cynthia S. Crowson³, Eric L. Matteson⁴, Hilal Maradit Kremers⁵ and Marta Sánchez-Menéndez⁶, ¹Medical Scientist Training Program, Mayo Clinic Rochester, Rochester, MN, ²Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Rheumatology, Mayo Clinic, Rochester, MN, ⁵Health Sciences Research, Mayo Clinic, Rochester, MN, ⁶Centro Medico de Asturias, Oviedo, Spain
Background/Purpose: Patients diagnosed with rheumatoid arthritis and psoriatic arthritis (PsA) have an increased risk of multiple comorbidities that predispose them to cardiovascular disease (CVD). Although…
Abstract Number: 1865 • 2014 ACR/ARHP Annual Meeting
Increased Risk of Myocardial Infarction and Cerebrovascular Accidents after Diagnosis of Granulomatosis with Polyangiitis: A General Population-Based Cohort Study
Neda Amiri¹, Natasha Dehghan², Eric C. Sayre³, Kamran Shojania¹ and J. Antonio Avina-Zubieta⁴, ¹Rheumatology, University of British Columbia, Vancouver, BC, Canada, ²University of British Columbia, Vancouver, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada
Background/Purpose Limited literature is available on the incidence of myocardial infarction (MI) and cerebrovascular accidents (CVA) in patients with Granulomatosis with Polyangiitis (GPA). We assessed…
Abstract Number: 1081 • 2014 ACR/ARHP Annual Meeting
Prediction of Mortality Risk Related to Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus (SLE) vs Anti-Phospho-Lipid-Antibody (aPL) syndrome
Khushboo Sheth¹, Tapan Mehta², Sonam Puri¹, Ronak Soni³ and Kathan Mehta⁴, ¹Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ²Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ³Internal Medicine, Government Medical College, Surat, India, ⁴Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA
Background/Purpose : It is well-established that patients with co-existent Systemic Lupus Erythematosus (SLE) and Anti-Phospho-Lipid-Antibody (aPL) syndrome are at increased risk of cerebrovascular accidents (CVA).…
Abstract Number: 2386 • 2012 ACR/ARHP Annual Meeting
Disability and Mortality Related to Cerebrovascular Disease in Systemic Vasculitis
Jamal Mikdashi¹ and Marcia Wozniak², ¹Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, ²Department of Neurology, University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: Despite improved therapeutic strategies, patients with systemic vasculitis (SV) continue to experience serious morbidity and mortality from persistent low grade disease activity and permanent…
Abstract Number: 2221 • 2012 ACR/ARHP Annual Meeting
Major Adverse Cardiovascular Events Are More Common in Rheumatoid Arthritis Than in Psoriatic Arthritis and Are Associated with Different Risk Factors
Allen P. Anandarajah¹, Katherine C. Saunders², George W. Reed³, Alina U. Onofrei³, Jeffrey D. Greenberg⁴ and Christopher T. Ritchlin⁵, ¹Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, ²Corrona, LLC., Southborough, MA, ³University of Massachusetts Medical School, Worcester, MA, ⁴NYU Hospital for Joint Diseases, New York, NY, ⁵Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY
Background/Purpose: Rheumatoid Arthritis (RA) is associated with increased cardiovascular mortality and morbidity rates. Similarly several studies have reported an increased risk for cardiovascular events in…
Abstract Number: 1551 • 2012 ACR/ARHP Annual Meeting
Primary Angiitis of the Central Nervous System: Description of the First 52 Adult Patients Enrolled in the French COVAC’ Cohort
Hubert de Boysson¹, Mathieu Zuber², Olivier Naggara³, Jean-Philippe Neau⁴, Françoise Gray⁵, Marie-Germaine Bousser⁶, Isabelle Crassard⁶, Emmanuel Touze⁷, Pierre-Olivier Couraud⁸, Philippe Kerschen⁹, Catherine Oppenheim³, Olivier Detante¹⁰, Anthony Faivre¹¹, Nicolas Gaillard¹², Caroline Arquizan¹³, Boris Bienvenu¹⁴, Antoine Neel¹⁵, Loic Guillevin¹⁶, Christian Pagnoux¹⁷ and French Vasculitis Study Group and NeuroVascular Society¹⁸, ¹Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, ²Department of Neurology, Groupe Hospitalier Saint-Joseph, Université Paris Descartes, Paris, France, ³Department of Neuroradiology, Hôpital Sainte-Anne, Paris, France, ⁴Department of Neurology, Centre Hospitalier Universitaire La Milétrie, Poitiers, France, ⁵Department of Pathology, APHP Hôpital Lariboisière, Université Paris Diderot, Paris, France, ⁶Department of Neurology, APHP Hôpital Lariboisière, Université Paris Diderot, Paris, France, ⁷Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, Paris, France, ⁸Department of Cellular Biology, Institut Cochin, Paris, France, ⁹Department of Neurology, Centre Hospitalier Universitaire Henri Mondor, Créteil, France, ¹⁰Department of Neurology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France, ¹¹Department of Neurology, Hôpital d'Instruction des Armées Saint-Anne, Toulon, France, ¹²Department of Neurology, Centre Hospitalier de Perpignan, Perpignan, France, ¹³Department of Neurology, Hôpital Gui de Chauliac, Université Montpellier, Montpellier, France, ¹⁴Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, ¹⁵Department of Internal Medicine, Centre Hospitalier Universitaire de Nantes, Nantes, France, ¹⁶Internal Medicine, Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, ¹⁷Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, ¹⁸Paris, France
Background/Purpose: Primary angiitis of the central nervous system (PACNS) is rare and only 1 pediatric and 1 adult large cohorts including >30 PACNS patients have…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].